Luciani L, Carlier C, Leuk L, Clarenne J, et al. Clinical and economic outcomes of adding durvalumab to gemcitabine/cisplatin in advanced biliary tract cancers: A multicenter descriptive study. Clin Res Hepatol Gastroenterol 2025;49:102733.
PMID: 41271098